Brain: Tumours

The Department invests over £1.6 billion per year in research through the National Institute for Health and Care Research (NIHR). Cancer is a major area of NIHR spending at £141.6 million in 2024/25, reflecting its high priority.

We are committed to furthering our investment in brain cancer research and have already taken steps to stimulate scientific progress and build scientific capacity to do research on brain cancer.

In January 2026, the NIHR announced increased investment of over £25 million in the NIHR Brain Tumour Research Consortium. The world-leading consortium aims to transform outcomes for adults and children and their families who are living with brain tumours, ultimately reducing lives lost to cancer.

The NIHR has also announced a new partnership with Cancer Research UK (CRUK), with approximately £3 million to co-fund Brain Tumour Centres of Excellence, which includes the Children’s Brain Tumour Centre of Excellence. This investment will accelerate the move from foundational research to delivering innovative treatments for patients.

In addition, the NIHR is actively engaged with CRUK alongside the health departments of the devolved administrations, through joint funding of the Experimental Cancer Medicine Centre network, a United Kingdom-wide consortium of specialist centres dedicated to early phase clinical trials and translational cancer research, including those for brain tumours. They have both an adult and a paediatric network.

The NIHR continues to welcome funding applications for research into any aspect of human health and care, including paediatric brain cancer. These applications are subject to peer review and judged in open competition, with awards being made on the basis of the importance of the topic to the public and health and care services, value for money, and scientific quality.